New scan could pinpoint returning prostate cancer
NCT ID NCT06235099
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 3 study tested a radioactive tracer called Copper Cu 64 PSMA I&T, given as an injection, to improve PET/CT scans in 235 men with prostate cancer that may have returned after initial treatment (surgery or radiation). The goal was to see how accurately the scan could detect and locate cancer recurrence. If proven effective, this imaging method could help doctors decide on the best next steps for treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Copper Cu 64 PSMA I&T (a radioactive tracer injected into a vein for PET/CT imaging)
What this could lead to
If successful, this imaging method could help doctors more accurately locate where prostate cancer has returned, guiding better treatment decisions.
What could go wrong
This is a completed Phase 3 study, but the results are not yet published. The test may not be more accurate than existing scans, and false positives or negatives are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biogenix Molecular, LLC
Miami, Florida, 33165, United States
-
Carolina Urologic Research Center, LLC
Myrtle Beach, South Carolina, 29572, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Edward Hines Jr VA Hospital
Hines, Illinois, 60141, United States
-
Excel Diagnostics and Nuclear Oncology Center
Houston, Texas, 77042, United States
-
Florida Urology Partners
Tampa, Florida, 33615, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Great Plains Health, Diagnostic Imaging
North Platte, Nebraska, 69101, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Indiana University Health Neuroscience Center
Indianapolis, Indiana, 46202, United States
-
James J. Peters VA Medical Center
The Bronx, New York, 10468, United States
-
John Cochran VA Medical Center
St Louis, Missouri, 63106, United States
-
M Health Fairview University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
-
Providence Medical Foundation
Fullerton, California, 92835, United States
-
Providence Saint John's Health Center
Santa Monica, California, 90404, United States
-
Queens Hospital Center
Jamaica, New York, 11432, United States
-
SSM Health Saint Louis University Hospital
St Louis, Missouri, 63104, United States
-
San Francisco VA Medical Center
San Francisco, California, 94121, United States
-
Stanford Hospital & Clinics
Stanford, California, 94305, United States
-
The University of Kansas Hospital
Kansas City, Kansas, 66160, United States
-
Tower Urology
Los Angeles, California, 90048, United States
-
University of California, Irvine
Orange, California, 92868, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
-
Urology San Antonio
San Antonio, Texas, 78229, United States
-
Urology of Indiana, LLC
Carmel, Indiana, 46032, United States
-
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
-
VA Portland Health Care System
Portland, Oregon, 97239, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
XCancer
Omaha, Nebraska, 68130, United States